ImmuCell ICCC Stock
ImmuCell Price Chart
ImmuCell ICCC Financial and Trading Overview
| ImmuCell stock price | 9.87 USD |
| Previous Close | 9.49 USD |
| Open | 9.75 USD |
| Bid | 7.02 USD x 200 |
| Ask | 9.79 USD x 200 |
| Day's Range | 9.53 - 9.85 USD |
| 52 Week Range | 4.52 - 10.75 USD |
| Volume | 58.65K USD |
| Avg. Volume | 26.86K USD |
| Market Cap | 88.16M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.07 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ICCC Valuation Measures
| Enterprise Value | 94.13M USD |
| Trailing P/E | N/A |
| Forward P/E | -88.59091 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.945152 |
| Price/Book (mrq) | 3.0263975 |
| Enterprise Value/Revenue | 3.144 |
| Enterprise Value/EBITDA | 16 |
Trading Information
ImmuCell Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 41.71% |
| S&P500 52-Week Change | 22.66% |
| 52 Week High | 10.75 USD |
| 52 Week Low | 4.52 USD |
| 50-Day Moving Average | 8.98 USD |
| 200-Day Moving Average | 6.86 USD |
ICCC Share Statistics
| Avg. Volume (3 month) | 26.86K USD |
| Avg. Daily Volume (10-Days) | 23.78K USD |
| Shares Outstanding | 9.05M |
| Float | 6M |
| Short Ratio | 0.27 |
| % Held by Insiders | 32.11% |
| % Held by Institutions | 21.70% |
| Shares Short | 9.09K |
| Short % of Float | 0.11% |
| Short % of Shares Outstanding | 0.10% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:100 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -1.82% |
| Operating Margin (ttm) | 19.01% |
| Gross Margin | 42.58% |
| EBITDA Margin | 19.65% |
Management Effectiveness
| Return on Assets (ttm) | 4.59% |
| Return on Equity (ttm) | -1.87% |
Income Statement
| Revenue (ttm) | 29.93M USD |
| Revenue Per Share (ttm) | 3.31 USD |
| Quarterly Revenue Growth (yoy) | 28.39% |
| Gross Profit (ttm) | 12.75M USD |
| EBITDA | 5.88M USD |
| Net Income Avi to Common (ttm) | -545403 USD |
| Diluted EPS (ttm) | -0.07 |
| Quarterly Earnings Growth (yoy) | 34.20% |
Balance Sheet
| Total Cash (mrq) | 6.81M USD |
| Total Cash Per Share (mrq) | 0.75 USD |
| Total Debt (mrq) | 12.78M USD |
| Total Debt/Equity (mrq) | 43.86 USD |
| Current Ratio (mrq) | 4.82 |
| Book Value Per Share (mrq) | 3.22 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 4.47M USD |
| Levered Free Cash Flow (ttm) | 3.08M USD |
Profile of ImmuCell
| Country | United States |
| State | ME |
| City | Portland |
| Address | 56 Evergreen Drive |
| ZIP | 04103 |
| Phone | 207 878 2770 |
| Website | https://immucell.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 73 |
ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that improves the health and productivity of dairy and beef cattle in the United States and internationally. It operates through two segments, Scours and Mastitis. The company offers First Defense, an orally delivered scours preventive product for calves with claims against E. coli, coronavirus, and rotavirus; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. It also provides California Mastitis Test, a quick on-farm diagnostic that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, a bivalent gel tube formulation. In addition, the company developing Re-Tain Drug Product, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is based in Portland, Maine.
Q&A For ImmuCell Stock
What is a current ICCC stock price?
ImmuCell ICCC stock price today per share is 9.87 USD.
How to purchase ImmuCell stock?
You can buy ICCC shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ImmuCell?
The stock symbol or ticker of ImmuCell is ICCC.
Which industry does the ImmuCell company belong to?
The ImmuCell industry is Biotechnology.
How many shares does ImmuCell have in circulation?
The max supply of ImmuCell shares is 9.05M.
What is ImmuCell Price to Earnings Ratio (PE Ratio)?
ImmuCell PE Ratio is now.
What was ImmuCell earnings per share over the trailing 12 months (TTM)?
ImmuCell EPS is -0.07 USD over the trailing 12 months.
Which sector does the ImmuCell company belong to?
The ImmuCell sector is Healthcare.
ImmuCell ICCC included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25587.04 USD — |
-2.21
|
13.85B USD — | 25513.26 USD — | 25882.57 USD — | — - | 13.85B USD — |
|
US Tech Composite Total Return
XCMP
US
|
31560.2 USD — |
-2.21
|
— — | 31469.2 USD — | 31924.72 USD — | — - | — — |
|
US Tech Capital Market Composite
RCMP
US
|
146.53 USD — |
-0.75
|
— — | 144.14 USD — | 148.72 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1184.66 USD — |
+0.75
|
— — | 1174.72 USD — | 1192.68 USD — | — - | — — |
- {{ link.label }} {{link}}